Analysis of positional candidate genes in the AAA1 susceptibility locus for Abdominal Aortic Aneurysms on chromosome 19

Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, USA.
BMC Medical Genetics (Impact Factor: 2.08). 01/2011; 12(1):14. DOI: 10.1186/1471-2350-12-14
Source: PubMed


Abdominal aortic aneurysm (AAA) is a complex disorder with multiple genetic risk factors. Using affected relative pair linkage analysis, we previously identified an AAA susceptibility locus on chromosome 19q13. This locus has been designated as the AAA1 susceptibility locus in the Online Mendelian Inheritance in Man (OMIM) database.
Nine candidate genes were selected from the AAA1 locus based on their function, as well as mRNA expression levels in the aorta. A sample of 394 cases and 419 controls was genotyped for 41 SNPs located in or around the selected nine candidate genes using the Illumina GoldenGate platform. Single marker and haplotype analyses were performed. Three genes (CEBPG, PEPD and CD22) were selected for DNA sequencing based on the association study results, and exonic regions were analyzed. Immunohistochemical staining of aortic tissue sections from AAA and control individuals was carried out for the CD22 and PEPD proteins with specific antibodies.
Several SNPs were nominally associated with AAA (p < 0.05). The SNPs with most significant p-values were located near the CCAAT enhancer binding protein (CEBPG), peptidase D (PEPD), and CD22. Haplotype analysis found a nominally associated 5-SNP haplotype in the CEBPG/PEPD locus, as well as a nominally associated 2-SNP haplotype in the CD22 locus. DNA sequencing of the coding regions revealed no variation in CEBPG. Seven sequence variants were identified in PEPD, including three not present in the NCBI SNP (dbSNP) database. Sequencing of all 14 exons of CD22 identified 20 sequence variants, five of which were in the coding region and six were in the 3'-untranslated region. Five variants were not present in dbSNP. Immunohistochemical staining for CD22 revealed protein expression in lymphocytes present in the aneurysmal aortic wall only and no detectable expression in control aorta. PEPD protein was expressed in fibroblasts and myofibroblasts in the media-adventitia border in both aneurysmal and non-aneurysmal tissue samples.
Association testing of the functional positional candidate genes on the AAA1 locus on chromosome 19q13 demonstrated nominal association in three genes. PEPD and CD22 were considered the most promising candidate genes for altering AAA risk, based on gene function, association evidence, gene expression, and protein expression.

Download full-text


Available from: Guy M. Lenk
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose of review: Family history is a risk factor for abdominal aortic aneurysm (AAA), suggesting that genetic factors play an important role in AAA development, growth and rupture. Identification of these factors could improve understanding of the AAA pathogenesis and be useful to identify at risk individuals. Recent findings: Many approaches are used to examine genetic determinants of AAA, including genome-wide association studies (GWAS) and DNA linkage studies. Two recent GWAS have identified genetic markers associated with an increased risk of AAA located within the genes for DAB2 interacting protein (DAB2IP) and low density lipoprotein receptor-related protein 1 (LRP1). In addition, a marker on 9p21 associated with other vascular diseases is also strongly associated with AAA. The exact means by which these genes currently control AAA risk is not clear; however, in support of these findings, mice with vascular smooth muscle cell deficiency of Lrp1 are prone to aneurysm development. Further current work is concentrated on other molecular mechanisms relevant in AAA pathogenesis, including noncoding RNAs such as microRNAs. Summary: Current studies assessing genetic mechanisms for AAA have significant potential to identify novel mechanisms involved in AAA pathogenesis of high relevance to better clinical management of the disease.
    No preview · Article · Mar 2013 · Current opinion in cardiology
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Abdominal aortic aneurysm (AAA) is a relatively common disease in elderly. Currently, only surgical treatment has been available for ruptured AAA. Thus, it is impressing to elucidate the molecular cellular mechanisms of AAA in order to develop the effective medications. AIM: This study is to explore the significant pathways and crosstalk between them in response to AAA. METHODS: The crosstalk of pathways was analyzed based on PPI datasets and expression profiles. RESULTS: It was showed that significant pathways included Cytokine-cytokine receptor interaction (hsa04060), B cell receptor signaling pathway, Chemokine signaling pathway (hsa04062), Cell adhesion molecules (CAMs) (hsa04514), and Hematopoietic cell lineage (hsa04640), which were in accordance with Lenk's results. Further analysis indicated that Chemokine signaling pathway (Hsa04062) and Cytokine-cytokine receptor interaction (Hsa04060) were both connected with the Cell adhesion molecules (CAMs) (Hsa04514) through the signal transduction (GO:0007165). B cell receptor signaling pathway (Hsa04662) and Cytokine-cytokine receptor interaction (Hsa04060) were both connected with the Natural killer cell mediated cytotoxicity (Hsa04650) through the apoptosis (GO:0006915) and signal transduction (GO:0007165), respectively. These crosstalks seemed to exit according to previous reports. We hope our study could provide insights for abdominal aortic aneurysm mechanism to some extent. CONCLUSIONS: We analyzed the significant pathways related with AAA through Sp and DAVID method. The results were in accordance with previous reports.
    No preview · Article · May 2013 · European review for medical and pharmacological sciences
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abdominal aortic aneurysm (AAA) disease is a common, morbid, and highly lethal pathology. Extraordinary efforts have been launched to determine the molecular and pathophysiological characteristics of AAAs. Although surgery is highly effective in preventing death by rupture for larger AAAs, no guidance or preventive therapy is currently available for the >90% of patients whose aneurysms are below the surgical threshold. Predictive animal models of AAA as well as human pathological samples have revealed a complex circuit of AAA formation and progression. The proteolytic destruction of matrix components of the aorta by different proteases has been extensively studied over many years. Recently, a novel class of small noncoding RNAs, called microRNAs, was identified as "fine-tuners" of the translational output of target genes; they act by promoting mRNA degradation. Their therapeutic potential in limiting AAA development appears very intriguing. Further, current studies assessing genetic and heritable associations for AAA disease have provided great insight into its pathogenesis, potentially enabling us to better clinically manage affected patients. Expected final online publication date for the Annual Review of Medicine Volume 65 is January 14, 2014. Please see for revised estimates.
    Full-text · Article · Nov 2013 · Annual review of medicine
Show more